| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.1M | +110.2% |
| Cost of Revenue | $12.9M | +26.1% |
| Gross Profit | -$3.8M | +35.6% |
| R&D Expense | $102.7M | +0.2% |
| SG&A Expense | $33.3M | +4.7% |
| Operating Income | -$158.4M | -7.2% |
| Pre-tax Income | -$152.1M | -1.8% |
| Income Tax | $171K | — |
| Net Income | -$152.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.9M | -25.1% |
| Short-term Investments | $83.1M | -54.4% |
| Accounts Receivable | $1.2M | +89.0% |
| Inventory | $2.3M | -1.2% |
| Current Assets | $123.3M | -46.2% |
| Total Assets | $147.5M | -42.7% |
| Current Liabilities | $39.2M | +112.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$106.9M | +10.0% |
| Capital Expenditures | $5.1M | -16.3% |
| Investing Cash Flow | $97.9M | +41.3% |
| Financing Cash Flow | -$671K | -103.2% |
| Free Cash Flow | -$112.0M | +10.3% |
| -2.0% |
| EPS (Basic) | -$2.85 | -331.8% |
| EPS (Diluted) | -$2.85 | -331.8% |
| Total Liabilities |
| $48.1M |
| +66.3% |
| Stockholders' Equity | $99.4M | -56.5% |